市场调查报告书
商品编码
1576932
腹腔镜设备的全球市场:洞察,竞争情形,市场预测:2030年Laparoscopic Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
2023年全球腹腔镜设备市场规模为113.5亿美元。预计到 2030 年,该市场将达到 191.3 亿美元,2024 年至 2030 年的预测期内复合年增长率为 9.14%。随着胃肠道癌和大肠癌盛行率的增加,对有效手术介入的需求也在增加。此外,由于微创手术具有众多优点,包括缩短住院时间和降低整体医疗成本,因此世界各地越来越多地采用微创手术,从而推动了腹腔镜设备市场的发展。此外,腹腔镜技术的进步,例如增强的成像系统、更精确的仪器和改善手术效果的机器人辅助设备,预计将在 2024 年至 2030 年的预测期内推动腹腔镜市场的成长。因素。
根据GLOBOCAN(2024)提供的最新数据和统计,预计2022年全球将有193万例直肠癌新病例,预计到2045年将增加329万例。
此外,根据国际癌症研究机构提供的最新数据(2024年),全球胃肠道癌症发生率为480万人。
随着全球大肠直肠癌和胃肠道癌症的发生率持续上升,人们越来越需要有效的手术解决方案,不仅能切除肿瘤,还能最大限度地减少与手术相关的身体创伤。腹腔镜手术因其许多优点已成为许多大肠直肠癌和胃肠道癌症手术的首选方法。对于大肠直肠癌,通常进行腹腔镜结肠切除术,涉及切除部分或全部结肠。腹腔镜方法使外科医生能够非常精确地切除结肠癌区域,同时保留尽可能多的健康组织。该手术还可以使肠道功能更早恢復正常,并减少对患者生活品质的整体影响。同样,对于胃癌等胃肠道癌症,常采用腹腔镜胃切除术切除部分或全部胃。这种微创方法对患者特别有利,因为它可以减少手术创伤并加速术后恢復,从而扩大全球腹腔镜设备市场。
本报告提供全球腹腔镜设备市场相关调查,提供市场概要,以及各产品类型,各用途,各终端用户,各地区趋势,及加入此市场的主要企业简介等资讯。
Laparoscopic Devices by Product Type (Laparoscopes, Insufflators, Suction/Irrigation Pumps, Energy Devices, Trocars, and Others), Application (General Surgery, Urological Surgery, Bariatric Surgery, Gynecological Surgery, Colorectal Surgery, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the increase in incidence of cancer such as gastrointestinal and colorectal cancer, growing adoption of minimally invasive surgeries across the globe, and growing advancement in laparoscopic technology.
The global laparoscopic devices market was valued at USD 11.35 billion in 2023, growing at a CAGR of 9.14% during the forecast period from 2024 to 2030, in order to reach USD 19.13 billion by 2030. As the prevalence of gastrointestinal and colorectal cancers rises, the demand for effective surgical interventions also increases. Furthermore, the growing adoption of minimally invasive surgeries across the globe due to numerous benefits, including shorter hospital stays and lower overall healthcare costs will drive the market for laparoscopic devices. Moreover, advancements in laparoscopic technology, such as enhanced imaging systems, more precise instruments, and robotic-assisted devices, which improve the outcomes of these surgeries are some of the key factors driving the growth of the laparoscopic market during the forecast period from 2024 to 2030.
Laparoscopic Devices Market Dynamics:
According to the recent data and stats provided by GLOBOCAN (2024), in 2022, globally, the estimated new cases of colerectum cancer were 1.93 million and the projections were estimated to increase 3.29 million by 2045.
Additionally, as per the recent updates provided by International Agency for Research on Cancer (2024), globally, the incidence of gastrointestinal cancer was 4.8 million.
As the incidence of colorectal and gastrointestinal cancers continues to rise globally, there is a growing need for effective surgical solutions that not only remove tumors but also minimize the physical trauma associated with surgery. Laparoscopic surgery has become the preferred approach for many colorectal and gastrointestinal cancer surgeries due to its numerous advantages. In the case of colorectal cancer, laparoscopic colectomy, which involves the removal of part or all of the colon, is a commonly performed procedure. The laparoscopic approach allows surgeons to remove the cancerous portion of the colon with high precision while preserving as much healthy tissue as possible. This technique also enables a quicker return to normal bowel function and reduces the overall impact on the patient's quality of life. Similarly, in gastrointestinal cancers, such as stomach cancer, laparoscopic gastrectomy is often used to remove part or all of the stomach. This minimally invasive approach is particularly beneficial for patients, as it reduces the surgical trauma and enhances postoperative recovery thereby escalating the overall market of laparoscopic devices across the globe.
Additionally, companies are amplifying their production of laparoscopic devices and securing regulatory approvals, thereby strategically expanding their market presence and driving further growth. For instance, in July, 2023, Genesis MedTech, announced that its ArtiSential(TM), a revolutionary series of articulating laparoscopic instruments, had successfully obtained approval from China's National Medical Products Administration (NMPA) for market release.
Thus, the factors mentioned above are likely to boost the market of laparoscopic devices during the forecasted period.
However, limitations such as reduced depth perception and visualization, and others and stringent regulatory concerns may hinder the future market of laparoscopic devices.
Laparoscopic Devices Market Segment Analysis:
Laparoscopic Devices by Product Type (Laparoscopes, Insufflators, Suction/Irrigation Pumps, Energy Devices, Trocars, and Others), Application (General Surgery, Urological Surgery, Bariatric Surgery, Gynecological Surgery, Colorectal Surgery, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of laparoscopic devices market the trocars are expected to hold a significant share in 2023. Trocars are playing a crucial role in boosting the overall market of laparoscopic devices due to their fundamental importance in minimally invasive surgical procedures. As a key component in laparoscopic surgery, trocars are used to create access ports through the abdominal wall, allowing surgeons to insert various instruments, including cameras and surgical tools, into the body with minimal tissue disruption. The increasing demand for laparoscopic procedures, driven by the numerous advantages of minimally invasive surgery-such as reduced postoperative pain, shorter recovery times, smaller scars, and lower risk of complications-has led to a growing need for high-quality, reliable trocars. These devices are essential for maintaining the integrity of the surgical site and ensuring the safe and efficient passage of instruments during the procedure. The market for trocars is further bolstered by continuous innovations in design and functionality, addressing specific surgical needs and improving overall outcomes. For instance, advancements in trocar technology have led to the development of bladeless, optical, and balloon-tip trocars, which minimize the risk of injury to internal organs and tissues during insertion. These improvements enhance the safety and precision of laparoscopic surgeries, making them more accessible to a broader range of patients and reducing the learning curve for surgeons. Additionally, disposable trocars are gaining popularity due to their ability to reduce the risk of cross-contamination and infection, which is increasingly important in modern healthcare settings.
For instance, in 2021, Espiner introduced the Espiner Trocar, a disposable laparoscopic trocar designed for precision and control providing safe and straightforward access to the peritoneal cavity. Thus, such strategic initiatives is poised to fuel substantial growth within the market of trocars. Hence, all the factors and product development are promoting the overall market growth of the segment thereby boosting the market of laparoscopic devices across the globe.
Hence, all the above-mentioned factors are expected to generate considerable revenue of the segment pushing the overall growth of the global laparoscopic devices market during the forecast period.
North America is expected to dominate the overall Laparoscopic Devices market:
North America is expected to account for the highest proportion of the laparoscopic devices market in 2023, out of all regions. This can be ascribed to the increasing prevalence of cancer such as gallbladder cancer, colorectal cancer, uterus cancer. Additionally, increasing adoption of minimally invasive surgeries, and the presence of key market players engaged in strategic activities across the region are expected to escalate the market of laparoscopic devices during the forecast period.
According to the data provided by the GLOBOCAN (2024), in 2022 the overall estimated new cases of gallbladder cancer, colorectal cancer, and uterus cancer was 279,000 in North America. As the incidence of these cancers rises, there is a growing demand for surgeries that offer effective tumor removal while minimizing patient recovery time, postoperative pain, and complications. Laparoscopic surgery, which involves the use of specialized devices to perform operations through small incisions, is particularly advantageous for these cancers. In gallbladder cancer, laparoscopic cholecystectomy allows for the precise removal of the gallbladder with less trauma to surrounding tissues. For colorectal cancer, laparoscopic colectomy and rectal surgery offer targeted removal of cancerous sections of the colon or rectum while preserving healthy tissue. In uterus cancer, laparoscopic hysterectomy enables the removal of the uterus with minimal impact on the patient's body, leading to faster recovery and fewer complications thereby escalating the overall market of laparoscopic device across the region.
Additionally, according to the American Society for Metabolic and Bariatric Surgery (2021), a total of 256,000 bariatric surgeries were performed in the United States. As the global obesity epidemic continues to rise, more individuals are turning to bariatric surgery, such as gastric bypass, sleeve gastrectomy, and adjustable gastric banding, as a viable option for long-term weight loss and the management of obesity-related conditions like type 2 diabetes, hypertension, and cardiovascular diseases. These surgeries are predominantly performed using laparoscopic techniques, which involve making small incisions through which specialized instruments, including cameras and surgical tools, are inserted. The benefits of laparoscopic bariatric surgery, such as reduced postoperative pain, shorter hospital stays, faster recovery times, and lower risk of complications, make it the preferred choice for both patients and surgeons thereby escalating the overall market across the region. Therefore, the above-mentioned factors are expected to bolster the growth of the laparoscopic devices market in the North America during the forecast period.
Laparoscopic Devices Market Key Players:
Some of the key market players operating in the laparoscopic devices market include Medtronic, Stryker, Shenzen Mindray Bio Medical Electronics Co., Ltd., Johnson & Johnson, Olympus Corporation, B. Braun Melsungen AG, Intuitive Surgical., CONMED Corporation., Becton, Dickinson and Company, Smith & Nephew, Microline Surgical., Optomic., Palliare Ltd, Sejong Medical Co., Ltd., BIOSISHEALING, Richard Wolf GmbH., Bolder Surgical (Hologic Inc.), RUDOLF Medical GmbH + Co. KG., EMOS Technology GmbH, Teleflex Incorporated., and others.
Recent Developmental Activities in the Laparoscopic Devices Market:
Key Takeaways From the Laparoscopic Devices Market Report Study:
Target Audience who can be Benefited From This Laparoscopic Devices Market Report Study:
Frequently Asked Questions for the Laparoscopic Devices Market: